Cost-effectiveness of dronedarone and standard of care compared with standard of care alone: US results of an ATHENA lifetime model

BACKGROUND: The first antiarrhythmic drug to demonstrate a reduced rate of cardiovascular hospitalization in atrial fibrillation/flutter (AF/AFL) patients was dronedarone in a placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Reynolds, Matthew R, Nilsson, Jonas, Åkerborg, Örjan, Jhaveri, Mehul, Lindgren, Peter
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2013
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3544268/
https://ncbi.nlm.nih.gov/pubmed/23326201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S36019
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi